Scarica l'app Stockscreener
24.37
0.37%
0.09
Dopo l'orario di chiusura:
24.37
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DOCS Giù?
Forum
Previsione
Precedente Chiudi:
$24.28
Aprire:
$24.57
Volume 24 ore:
2.23M
Relative Volume:
0.64
Capitalizzazione di mercato:
$4.50B
Reddito:
$637.78M
Utile/perdita netta:
$239.40M
Rapporto P/E:
20.46
EPS:
1.1909
Flusso di cassa netto:
$307.21M
1 W Prestazione:
-3.83%
1M Prestazione:
-2.60%
6M Prestazione:
-65.69%
1 anno Prestazione:
-59.92%
Intervallo 1D:
$24.00
$24.74
Intervallo di 1 settimana:
$24.00
$25.71
Portata 52W:
$23.53
$76.51
Doximity Inc Stock (DOCS) Company Profile
Nome
Doximity Inc
Settore
Industria
Telefono
(650) 549-4330
Indirizzo
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
24.37 | 4.50B | 637.78M | 239.40M | 307.21M | 1.1909 |
|
VEEV
Veeva Systems Inc
|
178.88 | 29.40B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
49.98 | 8.94B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
38.31 | 7.36B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
77.81 | 6.65B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.16 | 4.63B | 1.10B | 112.09M | 283.19M | 0.6096 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-01-08 | Aggiornamento | Truist | Hold → Buy |
| 2025-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-10-27 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-10-10 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Downgrade | Goldman | Neutral → Sell |
| 2025-07-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-02-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Neutral |
| 2024-11-14 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-18 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2024-01-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-08-09 | Downgrade | Needham | Buy → Hold |
| 2023-08-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Iniziato | Wells Fargo | Overweight |
| 2022-10-24 | Iniziato | Evercore ISI | In-line |
| 2022-10-13 | Iniziato | BTIG Research | Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Iniziato | Berenberg | Buy |
| 2022-05-18 | Reiterato | BofA Securities | Neutral |
| 2022-05-18 | Reiterato | Goldman | Buy |
| 2022-05-18 | Reiterato | Guggenheim | Buy |
| 2022-05-18 | Reiterato | Jefferies | Buy |
| 2022-05-18 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Reiterato | Needham | Buy |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-04 | Iniziato | BofA Securities | Neutral |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-17 | Iniziato | Robert W. Baird | Outperform |
| 2021-11-10 | Reiterato | Canaccord Genuity | Buy |
| 2021-11-10 | Reiterato | Goldman | Neutral |
| 2021-11-10 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Reiterato | Needham | Buy |
| 2021-11-10 | Reiterato | Piper Sandler | Overweight |
| 2021-08-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-19 | Iniziato | Goldman | Neutral |
| 2021-07-19 | Iniziato | JP Morgan | Overweight |
| 2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Iniziato | Piper Sandler | Overweight |
| 2021-07-19 | Iniziato | Raymond James | Outperform |
| 2021-07-19 | Iniziato | SVB Leerink | Outperform |
| 2021-07-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Doximity Inc Borsa (DOCS) Ultime notizie
Integral Health Asset Management Buys Stake in Doximity - National Today
Assessing Doximity (DOCS) Valuation After A Steep Share Price Pullback - Yahoo Finance
Is Doximity (DOCS) Now Offering Value After A 61% One Year Share Price Slide - simplywall.st
Capital Fund Management S.A. Acquires 108,937 Shares of Doximity, Inc. $DOCS - MarketBeat
Franklin Resources Inc. Increases Stake in Doximity, Inc. $DOCS - MarketBeat
First Trust Advisors LP Lowers Stock Holdings in Doximity, Inc. $DOCS - MarketBeat
Doximity (NASDAQ:DOCS) Insider Sells $63,622.16 in Stock - MarketBeat
Insider Selling: Doximity (NASDAQ:DOCS) Insider Sells $58,833.03 in Stock - MarketBeat
Sitaram Siddharth sells Doximity shares worth $58,833 - Investing.com UK
Sitaram Siddharth sells Doximity shares worth $58,833 By Investing.com - Investing.com Nigeria
Doximity interim PFO Sitaram sells $63,622 in shares - Investing.com South Africa
Doximity interim PFO Sitaram sells $63,622 in shares By Investing.com - Investing.com Australia
Capital World Investors Boosts Stake in Doximity - National Today
Capital World Investors Increases Position in Doximity, Inc. $DOCS - MarketBeat
Doximity upgraded at Raymond James on improving long-term growth visibility - MSN
American Century Companies Boosts Doximity Stake by 60% - National Today
American Century Companies Inc. Has $16.30 Million Position in Doximity, Inc. $DOCS - MarketBeat
What Analysts Are Saying About Doximity Stock - Sahm
Doximity Stock is Down 75% From Its Highs. Do Analysts See Recovery? - TIKR.com
Doximity (NASDAQ:DOCS) Receives "Outperform" Rating from Royal Bank Of Canada - MarketBeat
Rhenman & Partners Asset Management AB Increases Stake in Doximity, Inc. - National Today
Rhenman & Partners Asset Management AB Increases Position in Doximity, Inc. $DOCS - MarketBeat
Blair William & Co. IL Acquires 345,390 Shares of Doximity, Inc. $DOCS - MarketBeat
What Wall Street predicts for Doximity Inc. stock price2026 Key Lessons & Verified Chart Pattern Signals - Naître et grandir
(DOCS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Victory Capital Management Inc. Acquires 921,533 Shares of Doximity, Inc. $DOCS - MarketBeat
Assessing Doximity (DOCS) Valuation As Positive Analyst Sentiment Builds Around Its Telehealth Platform - Sahm
Doximity (NASDAQ:DOCS) Director Sells $52,000.00 in Stock - MarketBeat
Doximity (NYSE: DOCS) director trades options and sells 2,000 shares - Stock Titan
Is Doximity Inc in accumulation or distribution phaseJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Breakouts Watch: Is Doximity Inc stock a hidden gemWall Street Watch & Safe Capital Allocation Plans - baoquankhu1.vn
Hims and Hers Expands Its Technology Driven Consumer Health Platform - The Globe and Mail
DOCS SEC FilingsDoximity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Doximity Analysts Set $44.50 Average Price Target - National Today
Atlassian, C3.ai, Doximity, Braze, and Zeta Global Stocks Trade Up, What You Need To Know - Yahoo Finance
DOCS (NYSE: DOCS) insider to sell 2,000 shares via option exercise - Stock Titan
Is It Time To Reassess Doximity (DOCS) After A 62.5% One Year Slide? - Yahoo Finance
Is Doximity’s (DOCS) ViVE 2026 Pitch a Clue to Its Telehealth Moat? - simplywall.st
Bentley Systems, Guidewire Software, Health Catalyst, and Doximity Shares Skyrocket, What You Need To Know - The Globe and Mail
Intech Investment Management Trims Doximity Holdings - National Today
Ad Vital’s Dr. Shitel Patel Shares AI Prompting Strategies for Patient Growth in Doximity Article - FinancialContent
Doximity, Inc. (DOCS) Stock Analysis: Navigating a 62.87% Upside Potential in Health Information Services - DirectorsTalk Interviews
Intech Investment Management LLC Has $3.57 Million Holdings in Doximity, Inc. $DOCS - MarketBeat
William Blair Investment Management LLC Acquires 609,775 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. (NYSE:DOCS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Andra AP fonden Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Handelsbanken Fonder AB Acquires 180,700 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity CEO ViVE 2026 Talk Puts AI And Pharma Story In Focus - Sahm
Doximity, Inc. Hits New 52-Week Low at $23.57 Amid Market Decline - Markets Mojo
Doximity Investors' $31M Deal Over User Slowdown OK'd - Law360
ZoomInfo, SentinelOne, Toast, Doximity, and American Express Global Business Travel Shares Are Soaring, What You Need To Know - Yahoo Finance
Doximity Inc Azioni (DOCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.66%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):